Human tumor-associated viruses and new insights into the molecular mechanisms of cancer (Q34614394)

3 August 2017

1 reference

title

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer (English)

1 reference

3 August 2017

D Martin

1

1 reference

3 August 2017

J S Gutkind

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

3 August 2017

1 reference

3 August 2017

27 Suppl 2

1 reference

3 August 2017

S31-42

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.351

3 August 2017

0 references

cites work

The HTLV-1 neurological complex

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Australia Antigen and the Biology of Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

A children's cancer dependent on climatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

BCL-2 family: regulators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Viral IL-6-induced cell proliferation and immune evasion of interferon activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Non-A, non-B post-transfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Do viral chemokines modulate Kaposi's sarcoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The possible role of viruses in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

21 January 2018

Historical background

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

KSHV vFLIP binds to IKK-gamma to activate IKK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

KSHV infection and the pathogenesis of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Cervical cancer: from Hippocrates through Rigoni-Stern to zur Hausen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Immunobiology and pathogenesis of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The role of p53 and pRB in apoptosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Small DNA tumor viruses: large contributors to biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The history of tumor virology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Global control of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

[Discovery of the first virus, the tobacco mosaic virus: 1892 or 1898?].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The human papillomavirus E6 protein and its contribution to malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Immune pathogenesis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Mucosal shedding of human herpesvirus 8 in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Molecular functions and biological roles of hepatitis B virus x protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Phase-dependent immune evasion of herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

A humble chicken virus that changed biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The cat and mouse games that genes, viruses, and cells play

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

AIDS and associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Papillomaviruses in the causation of human cancers - a brief historical account

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

A novel type of human papillomavirus associated with genital neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Vaccine against human hepatitis B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Virus-like particles in sera of patients with infectious and serum hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

31 March 2020

Classic Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

inferred from DOI database lookup

7 January 2021

based on heuristic

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.351

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2009.351

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference